by EmVenio | Jun 1, 2023 | Press Release
Esteemed pharmaceutical leader Dr. Neil Kurtz appointed to board chair DURHAM, N.C., June 1, 2023 – Clinical trial organization EmVenio Research today announced the inception of an advisory board of veteran industry leaders. The board will provide strategic oversight...
by EmVenio | May 23, 2023 | Webinar
Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent...
by EmVenio | May 18, 2023 | Press Release
DURHAM, N.C., May 18, 2023 /PRNewswire/ — EmVenio Research activated a mobile community research site in Chicago, Illinois, on the Illinois Medical District campus as part of a concerted effort to maximize diversity, equity and inclusion in research studies and...
by EmVenio | May 17, 2023 | Press Release
Durham, NC – May 17, 2023 – EmVenio Research, a company providing rapid and scalable mobile research sites in order to better reach and recruit diverse, underserved and high-risk communities, has partnered with Socially Determined, a social risk analytics...
by EmVenio | Apr 25, 2023 | Blog
EmVenio Research attended the World Vaccine Congress in Washington DC earlier this month. The conference, which took place from April 3rd to 6th, brought together industry leaders, scientists, and researchers from around the world to discuss the latest advancements in...
